BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2115154)

  • 1. Orofacial features of Scheie (Hurler-Scheie) syndrome (alpha-L-iduronidase deficiency).
    Keith O; Scully C; Weidmann GM
    Oral Surg Oral Med Oral Pathol; 1990 Jul; 70(1):70-4. PubMed ID: 2115154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent allelism of the Hurler, Scheie, and Hurler/Scheie syndromes.
    Mueller OT; Shows TB; Opitz JM
    Am J Med Genet; 1984 Jul; 18(3):547-56. PubMed ID: 6433708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybridization studies of fibroblasts from Hurler, Scheie, and Hurler/Scheie compound patients: support for the hypothesis of allelic mutants.
    Fortuin JJ; Kleijer WJ
    Hum Genet; 1980 Feb; 53(2):155-9. PubMed ID: 6766899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Compound Hurler-Scheie disease in 3 siblings].
    Goldberg G; Grützner P
    Klin Monbl Augenheilkd; 1985 Aug; 187(2):120-3. PubMed ID: 3932747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The iduronidase-deficient mucopolysaccharidoses: clinical and roentgenorgraphic features.
    Stevenson RE; Howell RR; McKusick VA; Suskind R; Hanson JW; Elliott DE; Neufeld EF
    Pediatrics; 1976 Jan; 57(1):111-22. PubMed ID: 813180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of alpha-L-iduronidase in cultured skin fibroblasts from alpha-L-iduronidase-deficient patients.
    Fujibayashi S; Minami R; Ishikawa Y; Wagatsuma K; Nakao T; Tsugawa S
    Hum Genet; 1984; 65(3):268-72. PubMed ID: 6421718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical spectrum of alpha-L-iduronidase deficiency.
    Roubicek M; Gehler J; Spranger J
    Am J Med Genet; 1985 Mar; 20(3):471-81. PubMed ID: 3922223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hurler-Scheie phenotype with parental consanguinity. Report of an additional case supporting the concept of genetic heterogeneity.
    Kaibara N; Katsuki I; Hotokebuchi T; Takagishi K; Kure T
    Clin Orthop Relat Res; 1983 May; (175):233-6. PubMed ID: 6404579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-L-iduronidase deficiency and possible Hurler-Scheie genetic compound. Clinical, pathologic, and biochemical findings.
    Winters PR; Harrod MJ; Molenich-Heetred SA; Kirkpatrick J; Rosenberg RN
    Neurology; 1976 Nov; 26(11):1003-7. PubMed ID: 824566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hurler-Scheie phenotype: a report of two pairs of inbred sibs.
    Kaibara N; Eguchi M; Shibata K; Takagishi K
    Hum Genet; 1979; 53(1):37-41. PubMed ID: 119701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four novel mutations underlying mild or intermediate forms of alpha-L-iduronidase deficiency (MPS IS and MPS IH/S).
    Tieu PT; Bach G; Matynia A; Hwang M; Neufeld EF
    Hum Mutat; 1995; 6(1):55-9. PubMed ID: 7550232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of alpha-L-iduronidase activity in various tissues from two sibs affected with presumably the Hurler-Scheie compound syndrome.
    Thompson JN; Finley SC; Lorincz AE; Finley WH
    Birth Defects Orig Artic Ser; 1975; 11(6):341-6. PubMed ID: 811284
    [No Abstract]   [Full Text] [Related]  

  • 13. The Hurler/Scheie phenotype in children from a consanguineous marriage: case report with electronmicroscopy of the conjunctiva and ERG.
    Jensen OA; Pedersen C; Vestermark S; Warburg M
    Metab Pediatr Ophthalmol; 1980; 4(3):133-4. PubMed ID: 6779061
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical discrimination of Hurler and Scheie syndromes.
    Hopwood JJ; Muller V
    Clin Sci (Lond); 1979 Sep; 57(3):265-72. PubMed ID: 38945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hurler/Scheie phenotype. Report of an inbred sibship with tapeto-retinal degeneration and electron-microscopie examination of the conjuctiva.
    Jensen OA; Pedersen C; Schwartz M; Vestermark S; Warburg M
    Ophthalmologica; 1978; 176(4):194-204. PubMed ID: 96404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucopolysaccharidosis type I.
    Wraith JE; Jones S
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Craniofacial abnormalities in a murine knock-out model of mucopolysaccharidosis I H: a computed tomography and anatomic study.
    Graupman P; Pan D; Konair B; Hartung S; McIvor S; Whitley C; Low W; Lam CH
    J Craniofac Surg; 2004 May; 15(3):392-8. PubMed ID: 15111796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucopolysaccharidosis type I Hurler-Scheie syndrome: a case report.
    Lamichhane S; Sapkota A; Sapkota S; Adhikari N; Aryal S; Adhikari P
    Ann Med Surg (Lond); 2024 Jan; 86(1):588-593. PubMed ID: 38222696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.
    Jameson E; Jones S; Remmington T
    Cochrane Database Syst Rev; 2016 Apr; 4():CD009354. PubMed ID: 27033167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.
    Jameson E; Jones S; Wraith JE
    Cochrane Database Syst Rev; 2013 Nov; (11):CD009354. PubMed ID: 24257962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.